Olga Katsarou

Athens, ESYE31 11527, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Enhancing Hemophilia Care: Real-World Outcomes Following Switching to Extended Half-Life Factor VIII in Greece-The TOOL Study.

Enhancing Hemophilia Care: Real-World Outcomes Following Switching to Extended Half-Life Factor VIII in Greece-The TOOL Study.

Journal: Life (Basel, Switzerland)

Published: April 17, 2026

Disease burden and unmet medical need in severe hemophilia in Greece: insights from clinicians and patients.

Disease burden and unmet medical need in severe hemophilia in Greece: insights from clinicians and patients.

Journal: Frontiers in public health

Published: December 12, 2025

Switching hemophilia A patients to an extended half-life agent on a prophylactic basis: an economic appraisal.

Switching hemophilia A patients to an extended half-life agent on a prophylactic basis: an economic appraisal.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: July 09, 2025

A study of platelet function in patients with chronic immune thrombocytopenia treated with thrombopoietin receptor agonists.

A study of platelet function in patients with chronic immune thrombocytopenia treated with thrombopoietin receptor agonists.

Journal: Thrombosis research

Published: August 09, 2024

Flow cytometry vs conventional methods for the evaluation of anti-PF4/heparin antibodies: a single center study.

Flow cytometry vs conventional methods for the evaluation of anti-PF4/heparin antibodies: a single center study.

Journal: Bioanalysis

Published: July 18, 2024

Retraction notice to "Effect of steviol, steviol glycosides and stevia extract on glucocorticoid receptor signaling in normal and cancer blood cells" [Mol. Cell. Endocrinol. 460 (15 January 2018) 189-199].

Retraction notice to "Effect of steviol, steviol glycosides and stevia extract on glucocorticoid receptor signaling in normal and cancer blood cells" [Mol. Cell. Endocrinol. 460 (15 January 2018) 189-199].

Journal: Molecular and cellular endocrinology

Published: January 19, 2024

Outcome measures analysis following total knee arthroplasty in patients with severe haemophilic arthropathy of the knee.

Outcome measures analysis following total knee arthroplasty in patients with severe haemophilic arthropathy of the knee.

Journal: Biomedical reports

Published: September 05, 2023

Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe.

Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: October 25, 2022

Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART.

Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART.

Journal: PloS one

Published: December 08, 2021

Clinical, economic, and health-related quality of life burden associated with von Willebrand disease in adults and children: Systematic and targeted literature reviews.

Clinical, economic, and health-related quality of life burden associated with von Willebrand disease in adults and children: Systematic and targeted literature reviews.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: November 17, 2021

New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia.

New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia.

Journal: Thrombosis and haemostasis

Published: September 10, 2021

Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII-treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study.

Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII-treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: July 14, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026